Corrigendum to: IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway

IF 2.4 4区生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY

Current molecular pharmacology Pub Date : 2024-05-03 DOI:10.2174/187446721701240419165931

Li Yuan, Liang Zeng, Feng Ye, Kai Chen, Zhengrong Chen, Liping Li

引用次数: 0

Abstract

An error occurred in the funding details of the manuscript titled I“MPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway”, 2024; 17: e18761429257350 [1]. Original: This work was funded by grants from the National Natural Science Foundation of China (No. 81802346). Corrected: This work was funded by grants from the Basic Research Program of Guangzhou Science and Technology Program Project No. 202201010947. The original article can be found online at https://benthamscience.com/article/138645

查看原文本刊更多论文

更正： IMPDH2 通过激活 JunB 信号通路积极影响肝母细胞瘤细胞的增殖潜力IMPDH2 通过激活 JunB 信号通路积极影响肝母细胞瘤细胞的增殖潜力

原标题为《MPDH2 Positively Impacts the Proliferation Potentials of Hepatoblastoma Cells by Activating JunB Signaling Pathway》，2024; 17: e18761429257350 [1]的稿件的经费细节出现错误：本研究得到了广州市科技计划基础研究项目（编号：202201010947）的资助。 原文可在 https://benthamscience.com/article/138645 上查阅。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current molecular pharmacology Pharmacology, Toxicology and Pharmaceutics-Drug Discovery

CiteScore

4.90

自引率

3.70%

发文量

112

期刊介绍： Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology. Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.